PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
01-Oct-2024 PureTech to Present at CHEST 2024 Annual Meeting PureTech Health
01-Oct-2024 IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy effectiveness by 40% in patients with endometrial cancer AbilityPharma
01-Oct-2024 How to Find the Best Clinical Research Course for Your Career Goals Fusion technology solutions
30-Sep-2024 IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer Ichnos Glenmark Innovation (IGI),
30-Sep-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Johnson & Johnson
30-Sep-2024 CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line Janssen-Cilag
30-Sep-2024 DARZALEX® (daratumumab) subcutaneous (SC) formulation-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned Janssen-Cilag
30-Sep-2024 Decoding the Phases of Clinical Trials: From Concept to Market Fusion technology solutions
30-Sep-2024 Anticancer Drugs Market Growth Fueled by Advancements in Personalized Medicine Pristine Market Insights
30-Sep-2024 CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review CluePoints
27-Sep-2024 During European Myeloma Day, MPE highlights the importance of improving access to clinical trials Myeloma Patients Europe
27-Sep-2024 CQDM and Epitopea Fund the Development and Validation of CryptoMapTM, a Platform Enabling the Development of RNA-based Immunotherapies Epitopea
27-Sep-2024 Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies Bayer AG
27-Sep-2024 PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases PolTREG S.A.